Find clinical trials for COVID-19 in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Cincinnati, OH, USA:
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID...
Phase 2
Cincinnati, Ohio, United States and 54 other locations
States. The purpose of the study is to assess the safety and immunogenicity of recombinant influenza vaccine (RIV) + adjuvanted recombinant COVID...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 11 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Cincinnati, Ohio, United States and 144 other locations
The purpose of this study is to learn about the safety, tolerability, and immunogenicity of an updated vaccine against COVID-19, ca-...
Phase 3
Cincinnati, Ohio, United States and 27 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Cincinnati, Ohio, United States and 66 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Beavercreek, Ohio, United States and 209 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Cincinnati, Ohio, United States and 121 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Cincinnati, Ohio, United States and 33 other locations
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
The purpose of this trial is to evaluate immunogenicity and safety of CVXGA administered as a single intranasal dose against SARS-CoV-2 S-protein in...
Phase 2
Cincinnati, Ohio, United States and 9 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Dayton, Ohio, United States of America and 94 other locations
Clinical trials
Research sites
Resources
Legal